View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
November 17, 2021

Robotics-related deals in the clinical trial operations industry increased in H1 2021

Robotics-related deals made up 0.3% of all deals announced in the clinical trial operations sector in H1 2021.

By Saywah Mahmood

Robotics-related deals made up 0.3% of all deals announced in the clinical trial operations sector in the first six months of 2021.

This represents an increase from the figure of 0.1% in the last six months of 2020 and a decrease from 0.5% in the first six months of 2020.

GlobalData’s deals database looks at mergers, acquisitions and venture capital and private equity investments taking place daily between thousands of companies across the world.

Free White Paper

Machine learning hiring levels in clinical trials rose to a year-high in April 2022

By
Enter your details to receive the free paper:

In the first six months of 2021, the overall number of announced deals in the clinical trial operations sector increased by 9.9%, from the same period in 2020.

GlobalData's thematic approach to sector activity seeks to group key company information on investments to see which industries are best placed to deal with any issues they may encounter.

These themes, of which robotics is one, are best thought of as "any issue that keeps a CEO awake at night", and by tracking them, it becomes possible to ascertain which companies are leading the way on specific issues and which ones have some work to do.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU